Welcome to LookChem.com Sign In|Join Free

CAS

  • or

63843-42-5

Post Buying Request

63843-42-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

63843-42-5 Usage

General Description

4-(o-tolyloxy)piperidine is a chemical compound that consists of a piperidine ring with a substituted ether group attached at the 4-position. The o-tolyloxy group signifies that the substituent is an ortho-substituted tolyloxy, which is a phenyl group with a methoxy substituent in the ortho position. 4-(o-tolyloxy)piperidine has potential pharmaceutical applications due to its piperidine ring, which is a common structural motif in many biologically active molecules. Additionally, the presence of the ether group could make it suitable for use as a building block in the synthesis of other compounds. It is important to handle this compound with caution, as piperidine derivatives can be toxic and are known to have irritant effects.

Check Digit Verification of cas no

The CAS Registry Mumber 63843-42-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,8,4 and 3 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 63843-42:
(7*6)+(6*3)+(5*8)+(4*4)+(3*3)+(2*4)+(1*2)=135
135 % 10 = 5
So 63843-42-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO/c1-10-4-2-3-5-12(10)14-11-6-8-13-9-7-11/h2-5,11,13H,6-9H2,1H3

63843-42-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H50951)  4-(2-Methylphenoxy)piperidine, 97%   

  • 63843-42-5

  • 250mg

  • 532.0CNY

  • Detail
  • Alfa Aesar

  • (H50951)  4-(2-Methylphenoxy)piperidine, 97%   

  • 63843-42-5

  • 1g

  • 2149.0CNY

  • Detail

63843-42-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(2-methylphenoxy)piperidine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:63843-42-5 SDS

63843-42-5Downstream Products

63843-42-5Relevant articles and documents

Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profiles

Xiong, Lu,Gao, Chao,Shi, Yao-Jie,Tao, Xin,Rong, Juan,Liu, Kun-Lin,Peng, Cui-Ting,Wang, Ning-Yu,Lei, Qian,Zhang, Yi-Wen,Yu, Luo-Ting,Wei, Yu-Quan

, p. 11163 - 11176 (2018/03/26)

Nitrobenzothiazinone (BTZ) is a promising scaffold with potent activity against M. tuberculosis by inhibiting decaprenylphosphoryl-beta-d-ribose 2′-oxidase (DprE1). But unfavorable durability poses a challenge to further development of this class of agents. Herein, a series of BTZs bearing a variety of different substituents at the C-2 position were designed and synthesized. Compounds were screened for their antimycobacterial activity against Mycobacterium tuberculosis H37Ra and were profiled for metabolic stability, plasma protein-binding capacity and pharmacokinetics in vivo. In general, these new BTZs containing N-piperazine, N-piperidine or N-piperidone moiety have excellent antitubercular activity and low cytotoxicity. Several of the compounds showed improved microsomal stability and lower plasma protein-binding, opening a new direction for further lead optimization. And we obtained compound 3o, which maintained good anti-tuberculosis activity (MIC = 8 nM) and presented better in vitro ADME/T and in vivo pharmacokinetic profiles than reported BTZ compound PBTZ169, which may serve as a candidate for the treatment of tuberculosis.

DERIVATIVES OF TRIAZINES AND URACILS, THEIR PREPARATION AND THEIR APPLICATION IN HUMAN THERAPEUTICS

-

Page/Page column 30, (2010/04/03)

The present invention relates to derivatives of general formula I wherein : - W represents nitrogen, - R1 represents: ? a hydrogen or a linear or branched C1-C5 alkyl radical or, ? a C1-C3 alkyl radical substituted with groups such as trifluoromethyl, nitrile, hydroxy, C1-C3 alcoxy, C3-C6 alkoxyalkoxy, indolyl, thiophenyl, oxothiophenyl, C1-C3 N-alkylcarbamoyl groups or, ? a phenyl or pyridyl or naphthyl, or thiophenyl group optionally substituted with one or more groups such as halogen atoms, nitro, nitrile, trifluoromethyl, vinyl, methylsulfanyl, linear branched C1-C4 alkyl, linear or branched C1-C3 alkoxy groups, ? a C6 2-oxocycloalkyl radical - R2 represents a methyl or heptyl, - m, n are equal to 1, - V represents CH2, - X-Y represents -N- (C=O) -, -CH-O-, - Z represents a phenyl group substituted with one or more trifluoromethyl groups, halogen atoms or linear C1-C4 alkyl groups.

Method of treating pain and hypertension

-

, (2008/06/13)

3-[2-(Phenyloxycycloazalkyl)ethyl]indoles possessing antihypertensive, analgesic, and tranquilizing properties and process for their preparation are described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 63843-42-5